Mental Health

The FDA has approved an expanded indication of Soliris, an IV-administered monoclonal antibody for patients aged 6 years and older with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive.

Senators questioned Jay Bhattacharya, MD, PhD, about proposed NIH cuts to biomedical research, the safety of vaccines, and government transparency during his nomination hearing Wednesday to be the next director of the NIH.

Prefrontal transcranial direct current stimulation induced small- to medium-sized clinical effects in cognitive and clinical metrics in youths with ADHD with no serious adverse effects, according to a study published in JAMA Network Open.

Children with emotional or cognitive disabilities were more likely to report being suspended or expelled from school compared with children with physical disabilities or no disabilities, according to findings in Academic Pediatrics.

LinusBio last week announced the launch of a diagnostic aid designed to help clinicians rule out autism in children aged 1 to 36 months using a single strand of hair.

Researchers identified two groups of children with opposing support needs and symptom severity who are more likely to be diagnosed with autism spectrum disorder later, according to an analysis published in JAMA Pediatrics.

Suicide is one of the leading causes of death among youth in the United States, and pediatricians play an integral role in identifying patients who are at risk and connecting them to resources.

Although stimulant dispensing rates have rebounded to — or exceeded — pre-pandemic levels among girls, the dispensing rate among adolescent boys was almost 19% lower than it was before March 2020, according to study findings.

Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics.